Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma
Tannir, Nizar M., Schwab, Gisela, Grünwald, Viktor
Published in Current Oncology Reports (01.02.2017)
Published in Current Oncology Reports (01.02.2017)
Get full text
Journal Article
Book Review
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials
Ellingson, Benjamin M, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Zaw, Okkar, Mason, Warren P, Sahebjam, Solmaz, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Lai, Albert, Nghiemphu, Phioanh L, Pope, Whitney B, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Get full text
Journal Article
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Ellingson, Benjamin M, Gerstner, Elizabeth R, Smits, Marion, Huang, Raymond Y, Colen, Rivka, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Chakhoyan, Ararat, Gahrmann, Renske, Pope, Whitney B, Leu, Kevin, Raymond, Catalina, Woodworth, Davis C, de Groot, John, Wen, Patrick Y, Batchelor, Tracy T, van den Bent, Martin J, Cloughesy, Timothy F
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Basch, Ethan, Becker, Claus, Rogak, Lauren J, Schrag, Deborah, Reeve, Bryce B, Spears, Patricia, Smith, Mary Lou, Gounder, Mrinal M, Mahoney, Michelle R, Schwartz, Gary K, Bennett, Antonia V, Mendoza, Tito R, Cleeland, Charles S, Sloan, Jeff A, Bruner, Deborah Watkins, Schwab, Gisela, Atkinson, Thomas M, Thanarajasingam, Gita, Bertagnolli, Monica M, Dueck, Amylou C
Published in Clinical trials (London, England) (01.02.2021)
Published in Clinical trials (London, England) (01.02.2021)
Get more information
Journal Article
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice
Jakobovits, Aya, Amado, Rafael G, Yang, Xiaodong, Roskos, Lorin, Schwab, Gisela
Published in Nature biotechnology (01.10.2007)
Published in Nature biotechnology (01.10.2007)
Get full text
Journal Article
Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
Schaffer, Elisabeth M, Basch, Ethan M, Schwab, Gisela M, Bennett, Antonia V
Published in Clinical trials (London, England) (01.08.2021)
Published in Clinical trials (London, England) (01.08.2021)
Get full text
Journal Article
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Get full text
Journal Article
Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial
Dueck, Amylou C, Scher, Howard I, Bennett, Antonia V, Mazza, Gina L, Thanarajasingam, Gita, Schwab, Gisela, Weitzman, Aaron L, Rogak, Lauren J, Basch, Ethan
Published in JAMA oncology (01.02.2020)
Published in JAMA oncology (01.02.2020)
Get more information
Journal Article
Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies
WEINER, Louis M, BELLDEGRUN, Arie S, CRAWFORD, Jeffrey, TOLCHER, Anthony W, LOCKBAUM, Pamela, ARENDS, Rosalin H, NAVALE, Lynn, AMADO, Rafael G, SCHWAB, Gisela, FIGLIN, Robert A
Published in Clinical cancer research (15.01.2008)
Published in Clinical cancer research (15.01.2008)
Get full text
Journal Article
Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer
ROWINSKY, Eric K, SCHWARTZ, Garry H, ARENAS, Rosalin, FOON, Kenneth A, SCHWAB, Gisela, DUTCHER, Janice, GOLLOB, Jared A, THOMPSON, John A, VOGELZANG, Nicholas J, FIGLIN, Robert, BUKOWSKI, Ronald, HAAS, Naomi, LOCKBAUM, Pamela, LI, Yu-Ping
Published in Journal of clinical oncology (01.08.2004)
Published in Journal of clinical oncology (01.08.2004)
Get full text
Journal Article
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody
Foon, Kenneth A, Yang, Xiao-Dong, Weiner, Louis M, Belldegrun, Arie S, Figlin, Robert A, Crawford, Jeffrey, Rowinsky, Eric K, Dutcher, Janice P, Vogelzang, Nicholas J, Gollub, Jared, Thompson, John A, Schwartz, Garry, Bukowski, Ronald M, Roskos, Lorin K, Schwab, Gisela M
Published in International journal of radiation oncology, biology, physics (01.03.2004)
Published in International journal of radiation oncology, biology, physics (01.03.2004)
Get full text
Journal Article
Conference Proceeding
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
MacMillan, Margaret L., Couriel, Daniel, Weisdorf, Daniel J., Schwab, Gisela, Havrilla, Nancy, Fleming, Thomas R., Huang, Saling, Roskos, Lorin, Slavin, Shimon, Shadduck, Richard K., DiPersio, John, Territo, Mary, Pavletic, Steve, Linker, Charles, Heslop, Helen E., Joachim Deeg, H., Blazar, Bruce R.
Published in Blood (15.03.2007)
Published in Blood (15.03.2007)
Get full text
Journal Article
Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy
JOHNSTON, E, CRAWFORD, J, GARST, J, SCHWAB, G, BLACKWELL, S, BJURSTROM, T, LOCKBAUM, P, ROSKOS, L, YANG, B.-B, GARDNER, S, MILLER-MESSANA, M. A, SHOEMAKER, D
Published in Journal of clinical oncology (01.07.2000)
Published in Journal of clinical oncology (01.07.2000)
Get full text
Journal Article
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Powles, Thomas, Burotto, Mauricio, Escudier, Bernard, Bourlon, Maria T, Zurawski, Bogdan, Oyervides Juárez, Victor M, Hsieh, James J, Basso, Umberto, Shah, Amishi Y, Suárez, Cristina, Hamzaj, Alketa, Goh, Jeffrey C, Barrios, Carlos, Richardet, Martin, Porta, Camillo, Kowalyszyn, Rubén, Feregrino, Juan P, Żołnierek, Jakub, Pook, David, Kessler, Elizabeth R, Tomita, Yoshihiko, Mizuno, Ryuichi, Bedke, Jens, Zhang, Joshua, Maurer, Matthew A, Simsek, Burcin, Ejzykowicz, Flavia, Schwab, Gisela M, Apolo, Andrea B, Motzer, Robert J
Published in The New England journal of medicine (04.03.2021)
Published in The New England journal of medicine (04.03.2021)
Get full text
Journal Article
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, Ghassan K, Meyer, Tim, Cheng, Ann-Lii, El-Khoueiry, Anthony B, Rimassa, Lorenza, Ryoo, Baek-Yeol, Cicin, Irfan, Merle, Philippe, Chen, YenHsun, Park, Joong-Won, Blanc, Jean-Frederic, Bolondi, Luigi, Klümpen, Heinz-Josef, Chan, Stephen L, Zagonel, Vittorina, Pressiani, Tiziana, Ryu, Min-Hee, Venook, Alan P, Hessel, Colin, Borgman-Hagey, Anne E, Schwab, Gisela, Kelley, Robin K
Published in The New England journal of medicine (05.07.2018)
Published in The New England journal of medicine (05.07.2018)
Get full text
Journal Article
The clinical pharmacology of therapeutic monoclonal antibodies
Roskos, Lorin K., Davis, C. Geoffrey, Schwab, Gisela M.
Published in Drug development research (01.03.2004)
Published in Drug development research (01.03.2004)
Get full text
Journal Article
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment
Thanarajasingam, Gita, Basch, Ethan, Mead-Harvey, Carolyn, Bennett, Antonia V., Mazza, Gina L., Schwab, Gisela, Roydhouse, Jessica, Rogak, Lauren J., Dueck, Amylou C.
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article